Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Smoking Cessation 1Ovarian Neoplasms 1Neoplasms 1Mental Disorders 1Hematopoietic and Lymphoid System Neoplasm 1Hematologic Neoplasms 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 9Cetuximab 5Surveys and Questionnaires 4Cisplatin 4dostarlimab 2abemaciclib 2Standard of Care 2Docetaxel 2Carboplatin 2130-nm albumin-bound paclitaxel 2ulixertinib 1trastuzumab deruxtecan 1toripalimab 1tislelizumab 1tipifarnib 1ribociclib 1repotrectinib 1patritumab deruxtecan 1palbociclib 1olaparib 1nimotuzumab 1monalizumab 1ibrutinib 1fludarabine 1exemestane 1entrectinib 1ebselen 1durvalumab 1disitamab vedotin 1avelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Behavior Therapy × 30 days × Clear all
NCT01098955 2026-05-22

Smoking Cessation Treatment for Head & Neck Cancer Patients

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
51 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡